DDS for Dacarbazine by combining CD encapsulation with gold nanoparticles

Posted by

Dacarbazine (DB) is an antineoplastic drug extensively used in cancer therapy. However, present limitations on its performance are related to its low solubility, instability, and non-specificity. To overcome these drawbacks, DB was included in β-cyclodextrin (βCD), which increased its aqueous solubility and stability. This new βCD@DB complex has been associated with plasmonic gold nanoparticles (AuNPs), and polyethylene glycol (PEG) has been added in the process to increase the colloidal stability and biocompatibility. Different techniques revealed that DB allows for a dynamic inclusion into βCD, with an association constant of 80 M−1 and a degree of solubilization of 0.023, where βCD showed a loading capacity of 16%. The partial exposure of the NH2 group in the included DB allows its interaction with AuNPs, with a loading efficiency of 99%. The PEG-AuNPs-βCD@DB nanosystem exhibits an optical plasmonic absorption at 525 nm, a surface charge of −29 mV, and an average size of 12 nm. Finally, laser irradiation assays showed that DB can be released from this platform in a controlled manner over time, reaching a concentration of 56 μg/mL (43% of the initially loaded amount), which, added to the previous data, validates its potential for drug delivery applications. Therefore, the novel nanosystem based on βCD, AuNPs, and PEG is a promising candidate as a new nanocarrier for DB.

 Schematic representation of the development of the PEG-AuNPs-CD@DB nanosystem: (a) formation of the CD@DB complex by drug inclusion into the cyclodextrin cavity, (b) coating of the AuNPs surface with the CD@DB complexes, and (c) release of the DB from the nanosystem triggered by laser irradiation.


Sebastián Quintana-Contardo, Orlando Donoso-González, Erika Lang, Ariel R. Guerrero, Michael Noyong, Ulrich Simon, Marcelo J. Kogan, Nicolás Yutronic and Rodrigo Sierpe (2023) Optimizing Dacarbazine Therapy: Design of a Laser-Triggered Delivery System Based on β-Cyclodextrin and Plasmonic Gold Nanoparticles. Pharmaceutics 15(2), 458; https://doi.org/10.3390/pharmaceutics15020458

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.